B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 1,698,749 shares of the company’s stock, valued at approximately $99,869,000. Corteva makes up approximately 1.0% of B. Metzler seel. Sohn & Co. Holding AG’s holdings, making the stock its 21st biggest holding. B. Metzler seel. Sohn & Co. Holding AG owned 0.25% of Corteva as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in CTVA. Orion Portfolio Solutions LLC raised its position in shares of Corteva by 6.6% in the 1st quarter. Orion Portfolio Solutions LLC now owns 31,258 shares of the company’s stock valued at $1,803,000 after buying an additional 1,924 shares in the last quarter. Acadian Asset Management LLC acquired a new position in Corteva during the 1st quarter worth approximately $25,000. Covestor Ltd increased its position in Corteva by 370.7% during the 1st quarter. Covestor Ltd now owns 1,544 shares of the company’s stock worth $89,000 after purchasing an additional 1,216 shares in the last quarter. Clearbridge Investments LLC increased its position in Corteva by 6.2% during the 1st quarter. Clearbridge Investments LLC now owns 887,209 shares of the company’s stock worth $51,165,000 after purchasing an additional 51,566 shares in the last quarter. Finally, UniSuper Management Pty Ltd increased its position in Corteva by 296.1% during the 1st quarter. UniSuper Management Pty Ltd now owns 26,026 shares of the company’s stock worth $1,501,000 after purchasing an additional 19,455 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
CTVA has been the subject of a number of research analyst reports. Wells Fargo & Company lowered their price objective on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a research report on Friday, August 2nd. Citigroup began coverage on shares of Corteva in a research report on Wednesday, October 23rd. They set a “buy” rating and a $68.00 price objective for the company. Oppenheimer restated an “outperform” rating and issued a $70.00 price target (up from $69.00) on shares of Corteva in a research report on Friday, November 8th. KeyCorp decreased their price target on shares of Corteva from $66.00 to $62.00 and set an “overweight” rating for the company in a research report on Friday, August 2nd. Finally, Argus cut shares of Corteva from a “buy” rating to a “hold” rating in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $63.68.
Corteva Stock Up 3.3 %
Shares of NYSE CTVA opened at $57.01 on Tuesday. The firm has a market cap of $39.18 billion, a PE ratio of 57.59, a P/E/G ratio of 1.77 and a beta of 0.77. Corteva, Inc. has a 12-month low of $43.89 and a 12-month high of $63.75. The company’s fifty day simple moving average is $58.36 and its 200 day simple moving average is $55.69. The company has a quick ratio of 0.96, a current ratio of 1.50 and a debt-to-equity ratio of 0.08.
Corteva Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.19%. The ex-dividend date is Monday, December 2nd. Corteva’s dividend payout ratio is presently 68.69%.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Read More
- Five stocks we like better than Corteva
- Best Stocks Under $10.00
- 3 High Flying Stocks That Could Stock Split in 2025
- What is a Dividend King?
- Retail Sector Comeback Plays: SPDR S&P Retail ETF, FND, and SHAK
- What Is WallStreetBets and What Stocks Are They Targeting?
- Top IoT Stocks: Why Samsara and Digi Are Thriving in 2025
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.